Gustafson Flashcards

1
Q

What is PK? PD?

A

PK: dose -> exposure
PD: exposure -> response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Is dose proportional to exposure?

A

Generally yes. There is a variability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PK parameters for IV bolus of infrequent doses?

A
  • Cmax: toxicity, efficacy
  • AUC: exposure
  • Terminal Half-life:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PK parameters for multiple doses given frequently?

A

Cmax, Cmin, t1/2, Tmax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What should you measure in the blood for prodrugs like cyclophosphamide PK studies?

A

The active metabolite (4-OH-CP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the difference between PK of CP and 4-OH-CP in dogs and cats?

A

Dogs are the best at metabolizing CP. Very effective CYP450. CP and 4-OH-CP tell a very different story. The drug itself seems like you are underdosing.
Cats don’t metabolize CP a lot, so CP and 4-OH-CP look quite the same.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Is DOX exposure variable?

A

A lot. The same dosage of 30 mg/m2 is used, but some dogs can show ~X2 exposure more than others. Nothing will predict that variability.
Intra-patient variability can be as high as inter-patient variability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is VBL exposure variable?

A

Even worse. ~7X variability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the endpoint of phase I clinical trial?

A

Toxicity
Only do safety and PK.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly